Therapeutic Area

Pharmaceuticals

Therapeutic area intelligence for Pharmaceuticals with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 2

Companies

Azurity Pharmaceuticals →

Bayer →

Assets

FDA →

Various Products →

Recent signals(2)

RegulatoryJune 29, 2026

FDA Orders Azurity Pharmaceuticals to Halt Distribution of Unapproved Compounding Kits

The FDA has mandated Azurity Pharmaceuticals Inc. to cease the distribution of unapproved drugs in their compounding kits.

RegulatoryJune 27, 2026

Bayer Plc Issues Class 3 Recall for Various Products Due to Impurity

Bayer Plc is recalling all stock of certain products due to an impurity identified above acceptable limits.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.